- Cyber attack occurred at 2:30 pm on Wednesday, all its data centers isolated
- Just a few days ago, Dr. Reddy’s got approval for trial of Russia’s Corona vaccine ‘Sputnik V’
Cyber attack Dr. Reddy after Russian corona vaccine get trial approval
Dr. Reddy’s, one of the country’s largest pharmaceutical companies, has stopped work in many of its factories spread across the world after the cyber attack on Dr. Reddy and has integrated its data center services. Giving information, he said that he has done this work as a precaution. Work will be started within the next 24 hours. Earlier, shares of the company fell by 4% in the stock market after the cyberattack was reported. Let me tell you that last month, Dr. Reddy’s and RDIF partnered with the clinical trial of Sputnik V vaccine and its supply in India. To which RDIF India has also been added. 100 million doses of vaccine have been entrusted with the supply.
Also read: Side effects of Work from Home; Cyber attacks on 75% companies increased, survey revealed
Work will begin in 24 hours
The company’s Chief Information Officer Mukesh Rathi said that all services could resume in the next 24 hours and the cyber attack would not have any major impact on the company’s work. According to sources, apart from India, the company has stopped work in plants in USA, Russia, UK and Brazil. It is worth noting that a few days ago, Dr. Reddy’s got the approval to conduct human trials of Russia’s Corona vaccine ‘Sputnik V’ in India.
Also read: Modi government gives relief to OCI, PIO cardholders and foreign nationals to visit India
Company shares fell by 4 percent
When the matter of cyber attack came to light, the shares of the company fell by up to 4 per cent, due to which the shares of the company reached Rs 4832.40. After which recovery in the shares of the company was also seen and till the close of the market, the shares of the company closed at Rs 5023.60. However, today the company’s shares opened at Rs 5046.90.